Arrivo BioVentures is a privately-held biopharmaceutical company focused on accelerating and developing biologics and small molecules through clinical development that have the potential to improve patient lives.
Visit Site
Location: United States, North Carolina, Morrisville
Employees: 11-50
Total raised: $94M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Rex Health... | rexhealthv... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 29.11.2023 | Series B | $45M | - |
| 25.05.2016 | - | $49M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
| 29.11.2023 | Arrivo BioVentures Raises $45M in Series B Financing | Arrivo BioVentures, a Morrisville, NC-based biopharmaceutical company, raised $45M in Series B fundi... | finsmes.co... |
| 25.05.2016 | Drug Development Company Arrivo BioVentures Launches with $4... | Morrisville, N.C.-based Arrivo BioVentures, a drug development company, launched with the closing of... | finsmes.co... |
| - | Arrivo BioVentures LLC | “ARRIVO has a portfolio of diverse late-stage drug candidates through partnering with investors, inn... | fastfounde... |